Back to Top

"One of today's leaders in investor relations and shareholder services"

Category Archives: Articles

Kannaway LLC (MJNA)

A Closer Look at Kannaway LLC

Kannaway LLC (MJNA)

We’re always in search of other leaders in the cannabis industry who support and provide products to those who utilize the healing powers of medicinal marijuana and other similar products. Kannaway LLC is a subsidiary of Medical Marijuana, Inc. (MJNA). Kannaway reigns as the first lifestyle network to provide hemp-based botanical products to consumers. Their innovated products supply consumers with access to herbal blends and oils that support health and wellness through natural means.

Who Kannaway Is

Kannaway continuously strives to provide individuals with holistically sound choices for supplements and skincare products. They’re the first direct marketing company of its kind to give consumers access to legal hemp products. In 2014, the Academy of Multi-level Marketing awarded them with the title of “Start-up of the Year,” which was attributed to their rapid growth and solid foundation. Today, they’re continuing to guide the path of the cannabis market in the …

Continue Reading

Posted in Articles| Tagged , , , , |
AXIM

Medical Cannabis-Based Gum Moves into Production for Clinical Trials

AXIM

As of May 2, 2017, one of the world leaders in cannabinoid research and development declared their product development partner, Quay Pharmaceuticals Ltd., also known as Quay Pharma, acquired a license from the British Home Office to continue research related to AXIM’s MedChew Rx® line of pharmaceutical chewing gum. This particular license allows the British-based pharmaceutical company to work with controlled drugs in order to continue with the development process of the product.

Currently, MedChew RX® is made with 5 mg of cannabidiol (CBD) as well as an equivalent dosage of tetrahydrocannabinol (THC). When the drug does hit the market, it’ll be used to treat pain and spasms in patients who have multiple sclerosis (MS). This particular condition is a degenerative disease that affects the central nervous system and disrupts how the brain and body communicate with one another. Current research published by the National Organization for the Reform …

Continue Reading

Posted in Articles| Tagged , , , |
Medical Marijuana (MJNA)

MJNA Financial Numbers Tell Story of a Company on the Rise

Medical Marijuana (MJNA)

Medical Marijuana, Inc., traded publicly under the ticker symbol MJNA, has made history as the world’s first cannabis company to be publicly traded in the United States. 2016 was a big year for the company with record growth, international import permissions being granted by multiple government agencies, and promising clinical trial results from MJNA’s revolutionary product lines.

Financial Growth

In the last quarter of 2016, Medical Marijuana, Inc.’s revenue increased by 66 percent compared to the first quarter of 2016. The company also had a Net Comprehensive Income increase of 731 percent compared to the same figure in 2015. Finishing out 2016 with a net income of greater than $8 million, the company is poised to break even more financial records in 2017. At least part of MJNA’s landmark success can be attributed to its portfolio of subsidiaries and investments, including new IP filings, international licensing and promising findings …

Continue Reading

Posted in Articles| Tagged , , , , |
Medical Marijuana, Inc. (MJNA)

MJNA in Washington on Capitol Hill Side by Side with Americans for Safe Access

Medical Marijuana, Inc.  (MJNA)

Obviously, when you purchase marijuana on the street, you’re not always sure what you’re getting. With different potencies and strains and even the fact that people lace weed with other drugs on occasion, buying marijuana from a dealer is a gamble. Not to mention, purchasing it on the streets is illegal. However, now that medical marijuana is becoming more well known and accepted throughout the country, many are lobbying for safe access to medicinal marijuana to alleviate any issues associated with purchasing marijuana and the regulation of it.

Medical Marijuana, Inc. (OTC: MJNA) are among those who are fighting for the cause. They were the ones to pave the way in the United States as the first publicly traded cannabis company. From April 7th to the 11th, representatives from MJNA attended the 5th Annual National Medical Cannabis Unity Conference at Omni Shoreham Hotel in Washington, DC. Experts, including scientists, …

Continue Reading

Posted in Articles| Tagged , , , |
AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc. and API Develop Marinol Alternative

AXIM Biotechnologies, Inc.

Medical marijuana has presented life-changing treatment options for patients around the world, but with strict laws in many regions preventing the use of such pharmaceutical alternatives, progress has been gradual. There is still significant stigma surrounding the effects of medical marijuana and its use in a clinical treatment setting. Despite the many positive studies associated with these products, opposition persists in many sectors of the market. Companies such as AXIM Biotechnologies, Inc. (OTCQX: AXIM) have long been at the forefront of medical marijuana research and development, facing opposition from lobbyists and other detractors who seek to keep the status quo within the pharmaceutical industry. Until recently, Insys Therapeutics was one of those companies.

In the past, Insys Therapeutics has been active in the opposition of general marijuana legalization, donating $500,000 to a group called Arizonans for Responsible Drug Policy in the summer of 2016. The group launched a campaign …

Continue Reading

Posted in Articles| Tagged , , , |
Medical Marijuana, Inc. (MJNA)

Medical Marijuana, Inc. Positioned Perfectly as New Studies Showcase How CBD Oil is Effective for Treating Epileptic Children

Medical Marijuana, Inc. (MJNA)

According to the Epilepsy Foundation, the incidence of epilepsy is highest in young children and older adults. There are currently 2.2 million people who are believed to have epilepsy in the United States alone, and many of those suffering are children whose symptoms prevent them from going to school and leading normal childhoods. Epileptic seizures can range from mild and infrequent to being characterized by violent and near-constant convulsions. The problem with many existing treatments for epilepsy is that they quite often come with debilitating side effects, are ineffective, or a combination of both. Children are even more severely affected by many of these negative side effects than adult patients, and their young age may limit the treatment options available to them.

Medical marijuana is an increasingly popular treatment option for children and adults with epilepsy. Around the world, there have been promising case studies on the positive effects …

Continue Reading

Posted in Articles| Tagged , , , |